88 search results for: patient burden

Pediatric EoE Disease <b>Burden</b> Infographic
Gastroenterology
Pediatric EoE Disease Burden Infographic
Infographic

Learn about pediatric EoE disease burden and why early identification is key for pediatric patients with EoE

View more
EoE <b>Burden</b> and Pathophysiology of Type 2 Inflammation
Gastroenterology
EoE Burden and Pathophysiology of Type 2 Inflammation
videoanimation

Learn about the significant burden that patients with EoE experience, and the role of type 2 inflammation in this chronic, progressive disease.

View more
Assessment of Smell Loss in CRSwNP Interactive Infographic
Rhinology
Assessment of Smell Loss in CRSwNP Interactive Infographic
interactivity

Use this educational tool to explore the daily burden of loss of smell for patients with CRSwNP.

View more
Inside the Hive: Type 2 Inflammatory Pathways in Chronic Spontaneous Urticaria
Dermatology
Inside the Hive: Type 2 Inflammatory Pathways in Chronic Spontaneous Urticaria
expert video

Join Dr. Jason Hawkes in discussing the burden of CSU and how type 2 inflammation contributes to the development of chronic wheals (hives) and angioedema

View more
The Weight of Breath: The Impact of Pediatric Asthma on <b>Patient</b>s and Caregivers
Pulmonology
The Weight of Breath: The Impact of Pediatric Asthma on Patients and Caregivers
videoanimation

Learn about the multifaceted burden of uncontrolled pediatric asthma on patients and their caregivers.

View more
CRSwNP Interactive <b>Patient</b> Case Tool
Rhinology
CRSwNP Interactive Patient Case Tool
interactivity

Meet Fernando. Journey through his clinical profile, applying guideline-based checklists to reach a consensus regarding his diagnosis.

View more
.
Congress
9
March
2024
Congress
The Benefits of Early Intervention in AD: More Than Skin Deep

Many AD treatment goals focus on clinical manifestations, so that if a patient is free of lesions, their disease is considered well controlled. However, the inflammatory process underlying AD reaches far beyond the skin, affecting patients in unique ways at different stages of their lives. Education on the importance of treating AD beyond the skin and altering the treatment approach to fit the individual patient will help improve clinical management and reduce long-term patient burden.

ERS-ISIAN 2025 | Treatable Traits in CRSwNP
Rhinology
ERS-ISIAN 2025 | Treatable Traits in CRSwNP
expert video

Join Prof. Sietze Reitsma for an insightful presentation that will delve into identifying and leveraging key characteristics to optimize patient management and treatment outcomes.

View more
EoE: A Chronic, Progressive, Type 2 Inflammatory Disease Infographic
Gastroenterology
EoE: A Chronic, Progressive, Type 2 Inflammatory Disease Infographic
Infographic

Learn about key drivers of type 2 inflammation in EoE and how they mediate progressive esophageal remodeling and impact patient burden

View more
ADVENT at ESPGHAN | Shedding Light on Pediatric Eosinophilic Esophagitis: Timely Identification and Management
Congress
17
May
2024
Congress
ADVENT at ESPGHAN | Shedding Light on Pediatric Eosinophilic Esophagitis: Timely Identification and Management

Join global experts Prof. Salvatore Oliva and Dr. Dhandapani Ashok for an educational symposium at ESPGHAN, as they discuss the burden and impact of underlying type 2 inflammation in eosinophilic esophagitis (EoE), and the importance of early diagnosis and management in pediatric patients.

ADVENT at IRS-ISIAN | The Importance of Understanding Smell Loss and Congestion in CRSwNP
Congress
5
April
2024
Congress
ADVENT at IRS-ISIAN | The Importance of Understanding Smell Loss and Congestion in CRSwNP

Join Profs. Sachio Takeno and Joaquim Mullol for an educational symposium highlighting the multifaceted burden associated with loss of smell and congestion in patients with uncontrolled CRSwNP.

ADVENT at ERS-ISIAN 2025
On Demand
ERS-ISIAN 2025 | Type 2 Inflammation and Disease Control in CRSwNP: Current Perspectives and Future Directions

In this educational presentation, Profs. Vibeke Backer and Sietze Reitsma cover key aspects of type 2 inflammation and its role in the pathogenesis and management of CRSwNP and practical strategies for optimizing disease control and improving patient outcomes.